Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,082,616,583
+$1,158,093,590 QoQ
Shares Held
31,825,084
-4.9% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#8
of 4,647 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORGES BANK holds $48,449,655,630 across 13 Drug Manufacturers - General names. JNJ ranks #2 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,471,413 | $13,759,158,041 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
31,825,084 | $8,082,616,583 | |
| 3 | ABBV |
AbbVie Inc.
|
25,554,538 | $6,430,543,942 | |
| 4 | AZN |
Astrazeneca PLC
|
33,864,172 | $6,421,324,294 | |
| 5 | MRK |
Merck & Co., Inc.
|
36,983,784 | $4,752,416,244 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
21,965,555 | $2,775,128,218 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,866,658 | $2,124,256,833 | |
| 8 | AMGN |
Amgen Inc
|
5,625,584 | $2,037,136,478 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,082,616,583 | 31,825,084 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $6,924,522,993 | 33,459,884 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $4,877,173,691 | 31,929,124 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,109,749,640 | 30,811,322 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $4,390,037,284 | 30,355,672 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,706,250,274 | 29,040,172 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $4,252,140,653 | 29,092,369 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,506,640,424 | 28,488,782 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $4,071,641,563 | 25,977,042 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,673,918,220 | 23,588,560 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $4,609,719,254 | 27,849,923 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $4,316,223,155 | 27,846,601 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $4,609,398,756 | 26,093,398 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,015,513,770 | 24,580,765 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $4,224,444,575 | 23,798,347 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $4,339,303,219 | 24,484,022 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $4,172,929,498 | 24,393,111 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $4,028,593,275 | 24,944,850 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $4,251,684,053 | 25,808,450 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $4,433,853,528 | 26,978,117 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $4,370,566,300 | 27,770,786 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $4,202,153,036 | 28,225,101 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $3,975,774,074 | 28,271,166 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $3,729,873,915 | 28,444,093 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||